Clinical Trial Update: Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing haploidentical peripheral blood stem cell plus cord blood versus haploidentical peripheral blood stem cell plus bone marrow f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hematological Malignancies, Hematopoietic Stem Cell Transplantation | Phase 3 | Status: COMPLETED